Shares of BKV Corporation (NYSE:BKV - Get Free Report) have been given an average rating of "Buy" by the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $28.13.
A number of research analysts have issued reports on BKV shares. Truist Financial decreased their price target on BKV from $31.00 to $30.00 and set a "buy" rating for the company in a report on Monday, March 17th. Evercore ISI boosted their target price on shares of BKV from $20.00 to $26.00 and gave the company an "outperform" rating in a research note on Friday, May 30th. Barclays increased their price target on shares of BKV from $28.00 to $29.00 and gave the stock an "overweight" rating in a report on Monday, May 12th. Finally, KeyCorp cut their price objective on shares of BKV from $27.00 to $25.00 and set an "overweight" rating for the company in a report on Tuesday, March 4th.
Get Our Latest Analysis on BKV
BKV Trading Down 8.1%
NYSE BKV traded down $1.96 during trading on Friday, hitting $22.16. The company's stock had a trading volume of 734,349 shares, compared to its average volume of 450,268. BKV has a fifty-two week low of $15.00 and a fifty-two week high of $26.78. The company has a debt-to-equity ratio of 0.13, a current ratio of 0.41 and a quick ratio of 0.39. The business's 50 day simple moving average is $21.66 and its 200-day simple moving average is $21.69.
BKV (NYSE:BKV - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.26. The firm had revenue of $216.13 million for the quarter, compared to analysts' expectations of $223.20 million. On average, analysts anticipate that BKV will post -1.82 EPS for the current year.
Insiders Place Their Bets
In related news, insider Eric S. Jacobsen sold 31,350 shares of the firm's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $22.02, for a total value of $690,327.00. Following the transaction, the insider directly owned 257,903 shares of the company's stock, valued at approximately $5,679,024.06. This trade represents a 10.84% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Ethan Ngo sold 64,998 shares of the firm's stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $23.00, for a total value of $1,494,954.00. Following the completion of the transaction, the insider owned 112,675 shares in the company, valued at approximately $2,591,525. This trade represents a 36.58% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 243,875 shares of company stock worth $5,231,273. Corporate insiders own 4.11% of the company's stock.
Institutional Investors Weigh In On BKV
A number of large investors have recently modified their holdings of the business. Geode Capital Management LLC purchased a new position in shares of BKV in the fourth quarter worth about $7,728,000. Bank of New York Mellon Corp acquired a new stake in BKV in the 4th quarter valued at about $695,000. Driehaus Capital Management LLC purchased a new position in BKV in the 4th quarter worth approximately $9,553,000. California State Teachers Retirement System purchased a new position in BKV in the 4th quarter worth approximately $26,000. Finally, Corebridge Financial Inc. acquired a new position in shares of BKV during the 4th quarter worth approximately $170,000.
BKV Company Profile
(
Get Free ReportBKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.
Further Reading

Before you consider BKV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.
While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.